Concepedia

Anna Passarelli

AP

Statistics

Publications

11

Citations

371

H-Index

10

Active since

2010

Affiliations

Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"(Current)

University of Bari Aldo Moro

Istituti di Ricovero e Cura a Carattere Scientifico

Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori

Centro di Riferimento Oncologico

Anna Passarelli is an author at Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale" specializing in medicine, tumor microenvironment, and immunology.

ORCID

Top concepts

Publications per year

2010–2024

11

Publications

11

Serum exosomes as predictors of clinical response to ipilimumab in metastatic melanoma

Marco Tucci, Anna Passarelli, Francesco Mannavola et al. · OncoImmunology · 2017 · 94 citations · Full text

, , +17

Immune‑related adverse events during anticancer immunotherapy: Pathogenesis and management (Review)

Luigia Stefania Stucci, Raffaele Palmirotta, Anna Passarelli et al. · Oncology Letters · 2017 · 64 citations · Full text

Tumor-derived exosomes promote the in vitro osteotropism of melanoma cells by activating the SDF-1/CXCR4/CXCR7 axis

Francesco Mannavola, Marco Tucci, Claudia Felici et al. · Journal of Translational Medicine · 2019 · 54 citations · Full text

Adverse drug reactions after intravenous rituximab infusion are more common in hematologic malignancies than in autoimmune disorders and can be predicted by the combination of few clinical and laboratory parameters: results from a retrospective, multicenter study of 374 patients

Giovanni D’Arena, Vittorio Simeon, Luca Laurenti et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2017 · 30 citations

, , +20

Alpelisib for PIK3CA-mutated advanced gynecological cancers: First clues of clinical activity

Anna Passarelli, Vittoria Carbone, Sandro Pignata et al. · Gynecologic Oncology · 2024 · 30 citations · Full text

1–5 of 11